Showing 1 - 14 results of 14 for search 'Laura A. Puzniak', query time: 0.08s Refine Results
  1. 1
    Retrospective Real-World Evaluation of Outcomes in Patients with Skin and Soft Structure Infections Treated with Tedizolid in an Outpatient Setting

    Retrospective Real-World Evaluation of Outcomes in Patients with Skin and Soft Structure Infections Treated with Tedizolid in an Outpatient Setting by Ravina Kullar, Laura A. Puzniak, Jason P. Swindle, Thomas Lodise

    Published 2020-01-01
    Get full text
    Article
  2. 2
    Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP).

    Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP). by Andrew F Shorr, Laura A Puzniak, Pinaki Biswas, Michael S Niederman

    Published 2015-01-01
    Get full text
    Article
  3. 3
    Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial

    Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial by Thomas Lodise, Joe Yang, Laura A. Puzniak, Ryan Dillon, Marin Kollef

    Published 2020-09-01
    Get full text
    Article
  4. 4
    The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012–2019

    The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) ba... by Marya D. Zilberberg, Brian H. Nathanson, Laura A. Puzniak, Ryan J. Dillon, Andrew F. Shorr

    Published 2022-10-01
    Get full text
    Article
  5. 5
    Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014–2019

    Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014–2019 by Marya D. Zilberberg, Brian H. Nathanson, Laura A. Puzniak, Noah W. D. Zilberberg, Andrew F. Shorr

    Published 2022-01-01
    Get full text
    Article
  6. 6
    Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019.

    Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019. by Marya D Zilberberg, Brian H Nathanson, Laura A Puzniak, Noah W D Zilberberg, Andrew F Shorr

    Published 2022-01-01
    Get full text
    Article
  7. 7
    A multicenter evaluation of antibacterial use in hospitalized patients through the SARS-Cov-2 pandemic waves

    A multicenter evaluation of antibacterial use in hospitalized patients through the SARS-Cov-2 pandemic waves by Laura A. Puzniak, Karri A. Bauer, Kalvin C. Yu, Janet A. Watts, ChinEn Ai, Vikas Gupta

    Published 2023-02-01
    Get full text
    Article
  8. 8
    Treatment Heterogeneity in <i>Pseudomonas aeruginosa</i> Pneumonia

    Treatment Heterogeneity in <i>Pseudomonas aeruginosa</i> Pneumonia by Aisling R. Caffrey, Haley J. Appaneal, J. Xin Liao, Emily C. Piehl, Vrishali Lopes, Laura A. Puzniak

    Published 2022-07-01
    Get full text
    Article
  9. 9
    Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa

    Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa by Haley J. Appaneal, Aisling R. Caffrey, Vrishali Lopes, Emily C. Piehl, Laura A. Puzniak, Kerry L. LaPlante

    Published 2022-10-01
    Get full text
    Article
  10. 10
    Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions

    Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions by Abby E. Rudolph, Farid L. Khan, Tanya G. Singh, Srinivas Rao Valluri, Laura A. Puzniak, John M. McLaughlin

    Published 2024-08-01
    Get full text
    Article
  11. 11
    Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation

    Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation by Karri A. Bauer, Laura A. Puzniak, Kalvin C. Yu, Lyn Finelli, Pamela Moise, ChinEn Ai, Janet A. Watts, Vikas Gupta

    Published 2022-11-01
    Get full text
    Article
  12. 12
    Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021)

    Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October... by Karri A. Bauer, Laura A. Puzniak, Kalvin C. Yu, Kenneth P. Klinker, Janet A. Watts, Pamela A. Moise, Lyn Finelli, Vikas Gupta

    Published 2023-07-01
    Get full text
    Article
  13. 13
    The Comparative Effectiveness of Ceftolozane/Tazobactam versus Aminoglycoside- or Polymyxin-Based Regimens in Multi-Drug-Resistant <i>Pseudomonas aeruginosa</i> Infections

    The Comparative Effectiveness of Ceftolozane/Tazobactam versus Aminoglycoside- or Polymyxin-Based Regimens in Multi-Drug-Resistant <i>Pseudomonas aeruginosa</i> Infections by Aisling R. Caffrey, Haley J. Appaneal, J. Xin Liao, Emily C. Piehl, Vrishali Lopes, Ryan J. Dillon, Laura A. Puzniak, Kerry L. LaPlante

    Published 2022-05-01
    Get full text
    Article
  14. 14
    Inappropriate Empiric Therapy Impacts Complications and Hospital Resource Utilization Differentially Among Different Types of Bacterial Nosocomial Pneumonia: A Cohort Study, United States, 2014–2019

    Inappropriate Empiric Therapy Impacts Complications and Hospital Resource Utilization Differentially Among Different Types of Bacterial Nosocomial Pneumonia: A Cohort Study, United... by Marya D. Zilberberg, MD, MPH, Brian H. Nathanson, PhD, Laura A. Puzniak, PhD, MPH, Noah W. D. Zilberberg, Andrew F. Shorr, MD, MPH, MBA

    Published 2022-04-01
    Get full text
    Article

Search Tools: